David Redfern
Vermögen: 6 Mio $ am 31.05.2026
Vermögen: 6 Mio $ am 31.05.2026
David Simon Redfern currently works at ViiV Healthcare Ltd., as Chairman from 2011, Human Genome Sciences, Inc., as Director from 2012, Aspen Pharmacare Holdings Ltd., as Non-Executive Director from 2015, Haleon UK Holdings Ltd., as Director, and GSK Plc, as President-Corporate Development.
Mr. Redfern also formerly worked at Haleon UK Holdings (No.2) Ltd., as Director from 2019 to 2022, GlaxoSmithKline South Africa (Pty) Ltd., as Finance Director-European Business, and PricewaterhouseCoopers Services Ltd., as Principal.
Mr. Redfern received his undergraduate degree from the University of Bristol.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GSK PLC 0,01 % | 09.06.2026 | 218.610 ( 0,01 % ) | 6 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01.05.2008 |
| ASPEN PHARMACARE HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 01.02.2015 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Vorsitzender | 01.04.2011 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Direktor/Vorstandsmitglied | 30.07.2012 |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | 18.07.2022 |
GlaxoSmithKline South Africa (Pty) Ltd.
GlaxoSmithKline South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline South Africa (Pty) Ltd. is a company based in Bryanston, South Africa. | Corporate Officer/Principal | - |
PricewaterhouseCoopers Services Ltd.
PricewaterhouseCoopers Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing, bookkeeping, business consulting and tax advisory services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Aspen Pharmacare Holdings Ltd.
Aspen Pharmacare Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals products | Health Technology |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline South Africa (Pty) Ltd.
GlaxoSmithKline South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline South Africa (Pty) Ltd. is a company based in Bryanston, South Africa. | Health Technology |
PricewaterhouseCoopers Services Ltd.
PricewaterhouseCoopers Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing, bookkeeping, business consulting and tax advisory services | Commercial Services |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen